Implementing an Enhanced Recovery from Surgery Pathway to Reduce Hospital Length of Stay After Primary Hip and Knee Arthroplasty: A Budget Impact Analysis for Australia

Author(s)

ABSTRACT WITHDRAWN

OBJECTIVES: To determine the impact on healthcare costs of implementing an enhanced short-stay model of care (ESS-MOC) for arthroplasty at a national level.

METHODS: A budget impact analysis was conducted for Australian publicly and privately funded hospitals providing hip and knee arthroplasty over the years 2023-2030. Population-based sample projections obtained from clinical registry and administrative datasets of all individuals receiving minor-complexity elective hip or knee arthroplasty for osteoarthritis were applied. The ESS-MOC assigned a conservative 30% of eligible patients to an enhanced recovery from surgery (ERAS) pathway comprising shortened acute ward stay (average 2 days versus 4 days with current care) and outpatient rehabilitation. The remaining 70% received a current practice clinical pathway. The primary outcome was total healthcare cost savings post-implementation of the ESS-MOC, with return on investment (ROI) ratio and hospital bed days utilised also estimated. Costs are presented in Australian dollars (AUD), at 2023 prices.

RESULTS: Estimated cost savings for 2023-2030 from implementing the ESS-MOC pathway were AUD641million (95% CI: AUD99million to AUD1250million). This corresponds to a ROI ratio of AUD9.88 (AUD2.3 to AUD18.9). Savings would be 8-fold higher in the private sector (AUD571million vs. AUD70million), primarily attributable to the >80,000 rehabilitation bed days saved annually in this sector. For the period 2023-2030, an estimated 337,000 (261,000 to 412,000) acute bed days could be saved (private sector 262,000 [200,000 to 324,000]; public sector 74,000 [57,000 to 92,000]). Total implementation costs for the ESS-MOC were estimated at AUD38million and AUD34million for the private and public sectors, respectively. Only a small proportion of eligible patients (2% and 10% in private and public, respectively) would need to move into the ERAS pathway to realize cost savings.

CONCLUSIONS: Implementation of an ESS-MOC for eligible arthroplasty patients in Australia would generate significant cost and resource savings, particularly in the private hospital sector.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

EE132

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis

Disease

Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal), Surgery

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×